1. Home
  2. HITI vs CABA Comparison

HITI vs CABA Comparison

Compare HITI & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.47

Market Cap

257.8M

Sector

N/A

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$3.04

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
CABA
Founded
2009
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.8M
319.6M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
HITI
CABA
Price
$2.47
$3.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$6.13
$14.57
AVG Volume (30 Days)
399.3K
2.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.65
N/A
Revenue Next Year
$16.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$0.99
52 Week High
$4.06
$3.78

Technical Indicators

Market Signals
Indicator
HITI
CABA
Relative Strength Index (RSI) 49.25 48.95
Support Level $2.46 $2.11
Resistance Level $2.69 $3.34
Average True Range (ATR) 0.08 0.26
MACD -0.00 -0.04
Stochastic Oscillator 33.33 13.22

Price Performance

Historical Comparison
HITI
CABA

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: